-+ 0.00%
-+ 0.00%
-+ 0.00%

Lumira Ventures Cancer Breakthrough Fund joins Altis Labs’ USD 25 million Series A round

PUBT·09/17/2026 13:39:25
Listen to the news
Lumira Ventures Cancer Breakthrough Fund joins Altis Labs’ USD 25 million Series A round
  • Lumira Capital Investment Management Inc’s Cancer Breakthrough Fund joined Altis Labs’ US$25 million Series A financing.
  • Altis Labs develops AI-based oncology trial endpoints that generate survival predictions from routine radiology scans to detect treatment effects earlier.
  • The round was co-led by OrbiMed, Qiming Venture Partners USA.
  • Proceeds will expand Altis’ AI models into more cancer types, scale deployments with global biopharma partners, push AI endpoints as a trial standard.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Lumira Capital Investment Management Inc published the original content used to generate this news brief on September 17, 2026, and is solely responsible for the information contained therein.